Collegium Pharmaceutical Inc.

Collegium Pharmaceutical, Inc. (Stoughton, MA) develops and markets specialty pain‑management drugs including Xtampza ER, Nucynta ER/IR, Jornay PM, Belbuca, and Symproic, positioning it as a leading provider of abuse‑deterrent and opioid‑treating therapies.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 357
HQ: Stoughton

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
COLL	Collegium Pharmaceutical Inc. Cap: 1.4B \| P/E: 27.9	EQUITY	NMS	USD	US19459J1043	Active	📈